MLL 2.0 – From See Behind to Go Beyond
Dr. Claudia Haferlach covers and explains the transformative role of technologic advancements, including artificial intelligence (AI) in hematology, particularly in leukemia diagnostics with emphasis on the use of AI-driven diagnostic techniques to improve the accuracy and efficiency of cytomorphology and karyotyping.
